Thermo Fisher Scientific said it would acquire contract researcher PPD for $17.4 billion as it looks to add more muscle to its pharmaceutical services business.
With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $1.7 billion to get viral vector producer Brammer Bio.